CDSCO License

CDSCO

CDSCO Issues a List of Drugs, Medical Devices, and Cosmetics – An Overview

calendar26 Oct, 2022
timeReading Time: 3 Minutes
list of Drugs

The CDSCO has noted that Spurious or Quality or Adulterated or Misbranded of Drugs products, medical devices and Cosmetic products are formulations manufactured concealing the true identity of the product and made to resemble another such product, especially any popular brand, to deceive the customer and cash in on the popularity of the original. The products may or may not contain active ingredients. Spurious or adulterated drugs and cosmetics products are usually manufactured by unlicensed anti-social elements but sometimes licensed manufacturers may also be involved. Such adulterated products are those products which are found to contain an adulterated or substituted product or contaminated with filth rendering it injurious to health. By taking into consideration, on 17th October, CDSCO (Central Drug Standard Control Organisation[1]) issued a list of Drugs, Medical Devices, and Cosmetics declared as Spurious or Quality or Adulterated or Misbranded for the month of September 2022. In this blog, we will discuss a list of Drugs, Medical Devices, and Cosmetics declared as Spurious or Quality or Adulterated or Misbranded for the month of September 2022, issued by CDSCO.

Total Number of Samples tested by CDSCO – List of Drugs, Medical Devices, and Cosmetics issued by CDSCO

Below is the table showing a total number of samples tested by CDSCO in the month of September 2022:

Particulars Number of Samples
Total Number of Samples Tested 1456
Total No. of Samples declared as Not of Standard Quality 59
Total No. of Samples declared as of Standard Quality 1397
Total No. of Samples declared as Misbranded _
Total No. of Samples declared as Spurious _

Detailed List of Drugs, Medical Devices, and Cosmetics issued by CDSCO for the Month of September 2022

Following is the list of Drugs, Medical Devices, and Cosmetics declared as Spurious or not of Standard Quality or Misbranded or Adulterated issued by CDSCO for the Month of September 2022:

Name of Medical Devices or Cosmetics or Drugs Reason for Failure
Pantoprazole Sodium Gastro Resistant Tablets I.P. Pantofer-40 Tablets Dissolution (Buffer Stage)
Ocean-OZ (Ofloxacin & Ornidazole Tablets) Dissolution
Ornigyl-O (Ofloxacin and Ornidazole Tablets I.P.) Dissolution
Paracetamol Tablets IP (Larkin) Dissolution
NTP-650 (Paracetamol Tablets I.P. 650 mg.) Dissolution
Paracetamol Tablets IP 650 mg Dissolution
Dried Ferrous Sulphate & Folic Acid Tablets IP Description
Montelukast Sodium & Levocetirizine Dihydrochloride Tablets IP (Viznil) Description
ALCIFLOX 500 (Ciprofloxacin Tablets IP) Dissolution
Rabeprazole Gastro Resistant Tablets I.P. 20 mg Assay
Ascorbic Acid Tablets IP 500 mg Description
WARCETIZ (Cetirizine Hydrochloride Tablets IP) Description
KOOCAL-500 (Calcium with Vitamin D Tablets IP) Identification & Assay of Vitamin D3
Glimepiride Tablets IP 1 mg. Glimvale-1 Tablets Dissolution
Levocetirizine Dihydrochloride Syrup pH
OMECAP (Omeprazole Capsules IP 20 mg) Dissolution
Ranitidine Tablets IP 150 mg (ACILOC 150) Description
IM-OK-(Levocetirizine Hydrochloride Tablets IP) Dissolution
Co-trimoxazole Tablets IP SS Disintegration
Rosuvastatin Calcium Tablets IP 10 mg Dissolution
Sin-DSR (Rabeprazole Sodium (EC) & Domperidone Sustained Release Capsules) Assay for Raberprazole Sodium
Atorvastatin Tablets IP 20 mg Dissolution
Levothyroxine Sodium Tablets IP 50 mcg Assay
Lvcipro 500 – tablets (Ciprofloxacin Hydrochloride Tablets IP) Dissolution
Zinc Sulphate Dispersible Tablets IP 20 mg Uniformity of Dispersion & Disintegration
MONTERUS-L (Montelukast Sodium & Levocetirizine Hydrochloride Tablets I.P.) Dissolution and Description
Azithromycin Oral Suspension IP 200 mg/ 5 ml Assay or Content of Anhydrous Azithromycin
ACILOC 150 (RANITIDINE Tablets IP 150 mg) Description
Azithromycin Tablets IP 500mg AZUSTAN-500 Tablets Dissolution
Moxmed-500 (Amoxycillin Capsule I.P. 500mg) Dissolution & Array
Telmisartan Tablets I.P. 40 mg Dissolution
AMITRYN-C (Chlordiazepoxide & Amitriptyline Hydrochloride Tablets U.S.P.) Assay of Chlordiazepoxide
Thirobal -5 (Carbimazole Tablets I.P. 5 mg) Thiamazole & other related substances
Secef – CV (Cefixime & Potassium Clavulanate Tablets) Assay of Cefixime and Postassium Clavulanate
Misopres -200 (Misoprostol Tablets I.P. 200 mcg) Assay
Misoprostol Tablets I.P. 200 mcg Assay
LEVOCET Levocetirizine Tablets IP 5 mg Description
BUDISON 0.5 Respules (Budenoside, Nebuliser Suspension BP (0.5 mg) – 2 ml Assay & Related Substances
Clopidogrel & Aspirin Tablets I.P. Free Salicylic Acid (Related substances for Asprin)
RL 500ml (Compound Sodium Lactate Injection IP) (Ringer Lactate Solution for Injection) Bacterial Endotoxins
Flavosil -200 (Flavoxate Hydrochloride Tablets IP 200 mg) Assay
Vildazem M 1000 (Vildagliptin 50 mg & Metformin Hydrochloride 1000 mg Tablets I.P.) Disintegration
Losacon-H (Losartan Potassium & Hydrochlorothiazide Tablets I.P.) Assay of Hydrochlorthiazide
Alumina, Magnesia & Simethicone Tablets U.S.P. Assay of Simethicone
Propoven Injection 50ml (Propofol Emulsion for Injection IP 10mg/ml) Free Fatty Acid and Assay
Propomit Injection 20 ml (Propofol Emulsion for Injection IP 10mg/ml) Free Fatty Acid
NEXOFOL Injection 20 ml (Propofol Emulsion for Injection IP 10mg/ml) Assay
Ciprofloxacin Tablets IP 500 mg Test for Dissolution
Norfloxacin Tablets I.P. 400 mg Dissolution Test
FEXOFENADINE HCL Tablets IP 120 mg (REFEXO Tablets 120 mg) Dissolution
DIVALPROEX SODIUM Tablets IP 500 mg Dissolution (Buffer Stage)
Prolongedrelease Sodium Valproate Tablet BP 500 mg Description
Zinc Sulphate Dispersible Tablets IP Disintegration test
THIOCOLCHICOSI DE CAPSULES IP 4 mg Assay
POVIDONE Iodine Solution IP 10% W/V pH & Assay
Propofol Emulsion for Injection IP 10 mg/ml (PROPOVEN INJECTION ) Description, pH, Free fatty acid, Propofol dimer, Bacterial Endotoxins Sterility
Propofol Injection IP 1%w/v (NEOROF INJECTION ) pH

Conclusion

The CDSCO comes with a list of Drugs, Medical Devices, and Cosmetics which are not of standard quality or spurious or misbranded every month. In September 2020, the CDSCO declared that it had tested 1456, of which 59 were not of standard quality and 1397 as of standard quality.

Read our Article:CDSCO Medical Device Registration for Paediatrics and Neonatology

CDSCO License

Request a Call Back

Are you human? : 8 + 9 =

Easy Payment Options Available No Spam. No Sharing. 100% Confidentiality